Abstract
Although glial proliferation of the epileptic loci is recognized for more than a century in certain focal epilepsies, the role of astrocytes in epileptic conditions is receiving significant attention only in recent years. The present review will highlight current knowledge about the various ways astrocytes control neuronal excitability and contribute to genesis, maintenance and suppression of seizures. Besides the widely recognized astrocytic tasks like glutamate clearance, the role of gliotransmission, glutamate, GABA and ATP release as well as gap junctional communication will also be discussed along with the contribution of blood-brain barrier dysfunction, inflammatory pathways and alterations in mircoRNA expression profile to epilepsy. The mechanisms described will help to understand the astrocytic mechanisms contributing to the antiepileptic effect of existing anti-epileptic drugs (AEDs) and current therapeutic strategies and also signifies the potential of specific astrocyte-based AED development.
Keywords: Astrocytes, blood-brain barrier, epilepsy, gap junctions, gliotransmission, inflammation.
Current Medicinal Chemistry
Title:Astrocytic Target Mechanisms in Epilepsy
Volume: 21 Issue: 6
Author(s): L. Heja
Affiliation:
Keywords: Astrocytes, blood-brain barrier, epilepsy, gap junctions, gliotransmission, inflammation.
Abstract: Although glial proliferation of the epileptic loci is recognized for more than a century in certain focal epilepsies, the role of astrocytes in epileptic conditions is receiving significant attention only in recent years. The present review will highlight current knowledge about the various ways astrocytes control neuronal excitability and contribute to genesis, maintenance and suppression of seizures. Besides the widely recognized astrocytic tasks like glutamate clearance, the role of gliotransmission, glutamate, GABA and ATP release as well as gap junctional communication will also be discussed along with the contribution of blood-brain barrier dysfunction, inflammatory pathways and alterations in mircoRNA expression profile to epilepsy. The mechanisms described will help to understand the astrocytic mechanisms contributing to the antiepileptic effect of existing anti-epileptic drugs (AEDs) and current therapeutic strategies and also signifies the potential of specific astrocyte-based AED development.
Export Options
About this article
Cite this article as:
Heja L., Astrocytic Target Mechanisms in Epilepsy, Current Medicinal Chemistry 2014; 21 (6) . https://dx.doi.org/10.2174/0929867320666131119160445
DOI https://dx.doi.org/10.2174/0929867320666131119160445 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Antioxidants: Therapeutic Prospects for Cancer and Neurological Diseases
Mini-Reviews in Medicinal Chemistry Recent Advancement in the Field of Anticonvulsants: A Review
Letters in Drug Design & Discovery The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction
Current Pharmaceutical Design Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration
Current Neuropharmacology Update on the Evaluation and Management of Brief Resolved Unexplained Events (Previously Apparent Life-Threatening Events)
Reviews on Recent Clinical Trials Genetics of Recurrent Vertigo and Vestibular Disorders
Current Genomics Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy
CNS & Neurological Disorders - Drug Targets Psychiatric Disorders and TRP Channels: Focus on Psychotropic Drugs
Current Neuropharmacology Pharmacological Approaches for Treatment-resistant Bipolar Disorder
Current Neuropharmacology Early Intervention in Psychosis: Rationale, Results and Implications for Treatment of Adolescents at Risk
Adolescent Psychiatry Transgenic Mouse Models of Parkinsons Disease and Huntingtons Disease
CNS & Neurological Disorders - Drug Targets Involvement of Potassium and Chloride Channels and Other Transporters in Volume Regulation by Spermatozoa
Current Pharmaceutical Design The Four Human γ-Aminobutyric Acid (GABA) Transporters: Pharmacological Characterization and Validation of a Highly Efficient Screening Assay
Combinatorial Chemistry & High Throughput Screening Monocyclic and Fused Azines and Azoles as Histamine H<sub>4</sub> Receptor Ligands
Current Medicinal Chemistry Structure-to-function Relationship of Carbohydrates in the Mechanism of Lysosomal Storage Disorders (LSDs)
Current Organic Chemistry The Safety of Medications for the Treatment of Bipolar Disorder During Pregnancy and the Puerperium
Current Drug Safety The Vitamin D Neuroendocrine System as a Target for Novel Neurotropic Drugs
CNS & Neurological Disorders - Drug Targets Applications of Artificial Neural Networks in Medical Science
Current Clinical Pharmacology Patent Selections
Recent Patents on Anti-Infective Drug Discovery Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier
Current Drug Metabolism